Christopher Fröhlich

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Multidrug Resistant

Klebsiella Pneumoniae

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

UiT Norges arktiske universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

UiT Norges arktiske universitet

Norway

PHD

Publications

Christopher Fröhlich, Vidar Sørum, Nobuhiko Tokuriki, Pål Jarle Johnsen, Ørjan Samuelsen
Evolution of β-lactamase-mediated cefiderocol resistance. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Christopher Fröhlich, João Alves Gama, Klaus Harms, Viivi H A Hirvonen, Bjarte Aarmo Lund, Marc W Van der Kamp, Pål J Johnsen, Ørjan Samuelsen, Hanna Kirsti Schrøder Leiros
Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations. mSphere 6 (2) (2021)
Ørjan Samuelsen, Ove Alexander Høgmoen Åstrand, Christopher Fröhlich, Adam Heikal, Susann Skagseth, Trine Josefine Olsen Carlsen, Hanna Kirsti Schrøder Leiros, Annette Bayer, Christian Schnaars, Geir Kildahl-Andersen, Silje Lauksund, Sarah Finke, Sandra Huber, Tor Gjøen, Adriana Magalhaes Santos Andresen, Ole Andreas Løchen Økstad, Pål Rongved
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo. Antimicrobial agents and chemotherapy 64 (6) (2020)
Christopher Fröhlich, Vidar Sørum, Ane Molden Thomassen, Pål Jarle Johnsen, Hanna-Kirsti S Leiros, Ørjan Samuelsen
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs. mSphere 4 (2) (2019)